Search
for

    Sort by

    Research 541–570 of 1000+

    1. Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study Journal of Clinical Medicine · 2022 · 6 citations
    2. Comorbidities in Androgenetic Alopecia: A Comprehensive Review Dermatology and therapy · 2022
    3. The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption Current Sexual Health Reports · 2018 · 8 citations
    4. A comment on the post-finasteride syndrome International Journal of Trichology · 2018 · 11 citations
    5. 5‐Alpha reductase inhibitor related litigation: A legal database review International Journal of Andrology · 2021 · 2 citations
    6. Serenoa repens induced erectile dysfunction: Underdiagnosis and phytovigilance British Journal of Clinical Pharmacology · 2021 · 1 citations
    7. Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease Frontiers in Neuroendocrinology · 2024
    8. Is There an Association between 5a Reductase Inhibitors and Metabolic Syndrome? A Narrative Review of the Literature Reviews on Recent Clinical Trials · 2024
    9. Дослідження ПРОСПЕКТ IV (ПРОСтамол: ПЕрспективи Комбінованої Терапії) у хворих на доброякісну гіперплазію передміхурової залози Scientific periodicals of Ukraine · 2020
    10. O que sabemos sobre os inibidores da 5 alfa redutase? Surgical and Cosmetic Dermatology · 2018
    11. Anti-inflammatory and anti-hyperplastic effect of Bazhengsan in a male rat model of chronic nonbacterial prostatitis Journal of pharmacological sciences · 2019 · 7 citations
    12. Beeinflussen Medikamente gegen das benigne Prostatasyndrom Stimmung oder Kognition? Der Urologe · 2019 · 3 citations
    13. Effect of dose reduction of dutasteride in combination with alpha-blockers in patients with lower urinary tract symptoms/benign prostatic enlargement Urology Annals · 2024 · 2 citations
    14. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1. Proceedings of the National Academy of Sciences of the United States of America · 1993 · 53 citations
    15. Effects of the use of finasteride on prostate volume and serum PSA in young patients Digital Library of Theses and Dissertations (Universidade de São Paulo) · 2015
    16. Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis. Urology Journal · 2020 · 3 citations
    17. Editorial Comment Urology · 2012 · 1 citations
    18. BPH: costs and treatment outcomes. PubMed · 2006 · 34 citations
    19. Editorial Comment Urology · 2013 · 1 citations
    20. Editorial Comment 2021
    21. Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques Scientific African · 2024
    22. An overview on 5α-reductase inhibitors Steroids · 2009 · 219 citations
    23. Finasteride: the first 5 alpha-reductase inhibitor. PubMed · 1993 · 34 citations
    24. Temperature-dependent phase transition microemulsions for enhanced transdermal delivery of finasteride and silodosin Scientific Reports · 2025
    25. Alternative androgen pathways WikiJournal of Medicine · 2023
    26. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide. PubMed · 1997 · 7 citations
    27. How Much Worse Will My Voiding Symptoms Get over Time? The Journal of Urology · 2013
    28. 5 Alpha-Reductase Inhibitory Potential of Solanum nigrum Effective for Management of Alopecia 2024
    29. 5α-Reductase Inhibitory Potential of <i>Hibiscus rosa sinensis</i>: Effective for the Management of Alopecia Journal of Natural Remedies · 2023
    30. The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial. PubMed · 2002 · 37 citations